Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets

Research output: Contribution to journalReview articlepeer-review

43 Scopus citations

Abstract

Mucins are large glycoproteins expressed on the epithelia that provide a protective barrier against harsh insults from toxins and pathogenic microbes. These glycoproteins are classified primarily as being secreted and membrane-bound; both forms are involved in pathophysiological functions including inflammation and cancer. The high molecular weight of mucins is attributed to their large polypeptide backbone that is extensively covered by glycan moieties that modulate the function of mucins and, hence, play an important role in physiological functions. Deregulation of glycosylation machinery during malignant transformation results in altered mucin glycosylation. This review describes the functional implications and pathobiological significance of altered mucin glycosylation in cancer. Further, this review delineates various factors such as glycosyltransferases and tumor microenvironment that contribute to dysregulation of mucin glycosylation during cancer. Finally, this review discusses the scope of mucin glycan epitopes as potential diagnostic and therapeutic targets.

Original languageEnglish (US)
Pages (from-to)211-225
Number of pages15
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1856
Issue number2
DOIs
StatePublished - Dec 1 2015

Keywords

  • Cancer
  • Carbohydrate antigen
  • Glycan
  • Glycosyltransferase
  • Mucin
  • O-glycosylation

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets'. Together they form a unique fingerprint.

Cite this